Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients
CompletedOBSERVATIONAL
Enrollment
18
Participants
Timeline
Start Date
November 29, 2018
Primary Completion Date
July 9, 2020
Study Completion Date
July 9, 2020
Conditions
Major Depressive DisorderHealty Controls
Trial Locations (1)
52621
Revital Amiaz, Ramat Gan
All Listed Sponsors
collaborator
Hebrew University of Jerusalem
OTHER
lead
The Chaim Sheba Medical Center
OTHER
NCT06439797 - Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients | Biotech Hunter | Biotech Hunter